(Q45044547)

English

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

scientific article published on 7 October 2016

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit